Stem cells and exosomes administered via intravenous (IV) injection are being explored for their potential to systemically aid in the repair and regeneration of damaged tissues and organs. Stem cells, especially mesenchymal stem cells (MSCs) derived from umbilical cord tissues can migrate to sites of inflammation or injury, where they secrete bioactive molecules that promote healing, modulate immune responses, and encourage tissue regeneration. These cells do not necessarily integrate into the damaged organs but exert paracrine effects—meaning their healing capabilities stem from the release of signals that influence nearby cells.

Exosomes, which are extracellular vesicles secreted by stem cells, are increasingly viewed as the key therapeutic component in stem cell therapy. These nano-sized vesicles carry proteins, RNA, and other signaling molecules that can modulate inflammation, stimulate angiogenesis (formation of new blood vessels), and support cellular repair across multiple organ systems. Administered IV, exosomes may reach various organs and tissues through circulation, targeting areas with active inflammation or dysfunction. While early studies and anecdotal reports are promising, the field is still in early clinical stages, with ongoing research needed to validate safety, dosage, and long-term efficacy, especially for conditions like liver disease, kidney injury, neurodegenerative disorders, and autoimmune diseases.

Contact Us